Does COVID increase the risk of Alzheimer’s disease?

COVID-19, even in mild cases, is linked to changes in Alzheimer’s disease-related brain biomarkers comparable to four years of aging. This study raises concerns about long-term neurological risks and cognitive decline post-COVID.

Verix boosts life science AI capabilities with start-up.ai acquisition

With the addition of start-up.ai’s capabilities, Verix can continue its growth by advancing its AI platform. Credit: LeoWolfert / shutterstock.com. Artificial intelligence (AI)-driven commercial optimisation

June 16, 2023

Clearmind Medicine Announces Publication of International Patent Application for Innovative MDMA-Based Combination Treatment | Psychedelic Invest

Vancouver, Canada, Sept. 06, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on

September 12, 2024

Fixing pulse oximeters requires federal might and possible legal action, researchers say

Work by device manufacturers to improve the performance of pulse oximeters on people with darker skin has progressed little since the Food and Drug Administration

December 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.